Transporters for dopamine, noradrenaline and 5-hydroxytryptamine (named DAT, NET and SERT, respectively) represent established targets for many pharmacological agents that affect brain function ...
Cognigenics’ initial therapeutics are designed to selectively downregulate the 5-hydroxytryptamine receptor 2A (5HT2A) post-synaptic neuronal receptors—a serotonin receptor subtype—in the ...
Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that the FDA ...
Under baseline conditions, body weight and food intake may be primarily regulated via the hypothalamic 5-hydroxytryptamine receptor (5-HTR) 2C, whereas following stress the 5-HTR 4 in the medial ...
SPARKS, NV / ACCESSWIRE / September 17, 2024 / , (OTC PINK:LUDG), a USA-based biotechnology company, is pleased to announce it has acquired all the intellectual property and patent of the mRNA Neuro ...
Although many studies were carried out to evaluate the role of melatonin in GERD based on its effect in alleviation of GERD symptoms only, the review of literature showed that no previous studies ...